Organization · Venture Capital
ATMA Capital
ATMA Capital is an early-stage venture capital firm focused on deep technology investments in the US and Asia. The firm aims to support scientific advancements that address universal challenges, particularly in health and sustainability.
Overview
What ATMA Capital does
What ATMA Capital is
ATMA Capital is an early-stage venture capital firm focused on deep technology investments in the US and Asia. The firm aims to support scientific advancements that address universal challenges, particularly in health and sustainability.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- May 1, 2026
Official channels
Find ATMA Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
ATMA Capital as a funder
Investment thesis
Atma Capital invests in early-stage deep technologies that improve human health, intelligence, connectivity, and environmental outcomes, focusing on digital technology, sustainability, and data-driven life sciences.
Focus narrative
Atma Capital focuses on investing in sectors such as digital technology, sustainability, and data-driven life sciences. The firm aims to support innovations that have a positive societal and environmental impact, particularly in health technology and deep tech.
Value beyond capital
Atma Capital provides strategic support to its portfolio companies by leveraging its team's expertise in technology and deep tech sectors. The firm aims to enable scientific founders to address universal challenges and elevate human potential through innovative solutions.
Terms and economics
- Typical check
- $500,000–$5,000,000
Focus and fit
- Stages
- Seed · Series A
- Regions
- North AmericaAsia
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 7
Portfolio context
Notable portfolio companies include: SiPhox Health: Develops accessible diagnostics through at-home health test kits. Yuva Biosciences: Focuses on anti-aging solutions via mitochondrial science. Uplift: Enhances athletic performance using artificial intelligence. Strand Therapeutics: Works on programmable mRNA for curative therapies. Clerio Vision: Improves vision care with femtosecond laser technology. Window Therapeutics: Develops breakthrough treatments for cancer. JOGO Health: MedTech and digital health company for chronic pain and neuromuscular disorders.
Common questions
What to know about ATMA Capital
Upseed classifies ATMA Capital under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 1, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.